Literature DB >> 21933869

Involvement of progranulin in hypothalamic glucose sensing and feeding regulation.

Hyun-Kyong Kim1, Mi-Seon Shin, Byung-Soo Youn, Churl Namkoong, So Young Gil, Gil Myoung Kang, Ji Hee Yu, Min-Seon Kim.   

Abstract

Progranulin (PGRN) is a secreted glycoprotein with multiple biological functions, including modulation of wound healing and inflammation. Hypothalamic PGRN has been implicated in the development of sexual dimorphism. In the present study, a potential role for PGRN in the hypothalamic regulation of appetite and body weight was investigated. In adult rodents, PGRN was highly expressed in periventricular tanycytes and in hypothalamic neurons, which are known to contain glucose-sensing machinery. Hypothalamic PGRN expression levels were decreased under low-energy conditions (starvation and 2-deoxy-D-glucose administration) but increased under high-energy condition (postprandially). Intracerebrovetricular administration of PGRN significantly suppressed nocturnal feeding as well as hyperphagia induced by 2-deoxyglucose, neuropeptide Y, and Agouti-related peptide. Moreover, the inhibition of hypothalamic PGRN expression or action increased food intake and promoted weight gain, suggesting that endogenous PGRN functions as an appetite suppressor in the hypothalamus. Investigation of the mechanism of action revealed that PGRN diminished orexigenic neuropeptide Y and Agouti-related peptide production but stimulated anorexigenic proopiomelanocortin production, at least in part through the regulation of hypothalamic AMP-activated protein kinase. Notably, PGRN was also expressed in hypothalamic microglia. In diet-induced obese mice, microglial PGRN expression was increased, and the anorectic response to PGRN was blunted. These findings highlight a physiological role for PGRN in hypothalamic glucose-sensing and appetite regulation. Alterations in hypothalamic PGRN production or action may be linked to appetite dysregulation in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933869     DOI: 10.1210/en.2011-1221

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance.

Authors:  Jiali Liu; Huixia Li; Bo Zhou; Lin Xu; Xiaomin Kang; Wei Yang; Shufang Wu; Hongzhi Sun
Journal:  Mol Endocrinol       Date:  2015-02-09

2.  The anti-adipogenic effect of PGRN on porcine preadipocytes involves ERK1,2 mediated PPARγ phosphorylation.

Authors:  Hao Yang; Jia Cheng; Ziyi Song; Xinjian Li; Zhenyu Zhang; Yin Mai; Weijun Pang; Xin'e Shi; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2013-10-05       Impact factor: 2.316

3.  Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2α-dependent manner.

Authors:  Huixia Li; Bo Zhou; Jiali Liu; Fang Li; Yulong Li; Xiaomin Kang; Hongzhi Sun; Shufang Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Progranulin: at the interface of neurodegenerative and metabolic diseases.

Authors:  Andrew D Nguyen; Thi A Nguyen; Lauren Herl Martens; Laura L Mitic; Robert V Farese
Journal:  Trends Endocrinol Metab       Date:  2013-09-10       Impact factor: 12.015

Review 5.  Insights into the role of progranulin in immunity, infection, and inflammation.

Authors:  Jinlong Jian; Jessica Konopka; Chuanju Liu
Journal:  J Leukoc Biol       Date:  2012-10-22       Impact factor: 4.962

Review 6.  Mechanisms of granulin deficiency: lessons from cellular and animal models.

Authors:  Gernot Kleinberger; Anja Capell; Christian Haass; Christine Van Broeckhoven
Journal:  Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.590

7.  Glucose enhances leptin signaling through modulation of AMPK activity.

Authors:  Haoran Su; Lin Jiang; Christin Carter-Su; Liangyou Rui
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 8.  The role of progranulin in diabetes and kidney disease.

Authors:  Bruna Bellincanta Nicoletto; Luis Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

9.  Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus.

Authors:  Stefanie Hardt; Lucie Valek; Jinyang Zeng-Brouwers; Annett Wilken-Schmitz; Liliana Schaefer; Irmgard Tegeder
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

Review 10.  Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.

Authors:  Janis Bennion Callister; Stuart M Pickering-Brown
Journal:  Exp Neurol       Date:  2014-06-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.